Treatment response with mepolizumab in severe eosinophilic asthma patients with previous omalizumab treatment

BACKGROUND: We performed post hoc analyses to evaluate the effect of humanized monoclonal antibody mepolizumab in patients with severe eosinophilic asthma previously treated with omalizumab. METHODS: Data were collected from two randomized double‐blind, placebo‐controlled studies: MENSA (NCT01691521...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Allergy
Autors principals: Magnan, A., Bourdin, A., Prazma, C. M., Albers, F. C., Price, R. G., Yancey, S. W., Ortega, H.
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2016
Matèries:
ORIGINAL ARTICLES
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5089585/
https://ncbi.nlm.nih.gov/pubmed/27087007
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/all.12914
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars